Edition:
United Kingdom

Humanwell Healthcare Group Co Ltd (600079.SS)

600079.SS on Shanghai Stock Exchange

17.88CNY
15 Dec 2017
Change (% chg)

¥-0.30 (-1.65%)
Prev Close
¥18.18
Open
¥18.20
Day's High
¥18.20
Day's Low
¥17.60
Volume
7,228,049
Avg. Vol
10,849,825
52-wk High
¥21.50
52-wk Low
¥17.31

Select another date:

Fri, Dec 15 2017

BRIEF-Humanwell Healthcare Group completes investment in unit RFSW Investment Pte Ltd

* Says it invested 805.4 million yuan in wholly owned Singapore unit RFSW Investment Pte. Ltd

BRIEF-Humanwell Healthcare Group unit gets approval of clinical trial for Meisuoshuli tablets

* Says its Wuhan-based unit gets approval of clinical trial for Meisuoshuli tablets, which is used for anti-inflammatory, analgesic and antipyretic

BRIEF-Humanwell Healthcare's shareholder bought shares worth 143.7 mln yuan during Jun 28-Nov 29

* SAYS CONTROLLING SHAREHOLDER HAS BOUGHT 143.7 MILLION YUAN ($21.78 million) WORTH OF COMPANY SHARES BETWEEN JUNE 28 AND NOV 29 Source text in Chinese: http://bit.ly/2k9Y2AT Further company coverage: ($1 = 6.5966 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Humanwell Healthcare Group unit passes FDA approval

* Says its 75 percent-owned unit received approval for its soft capsule named Dutasteride Capsule from U.S Food and Drug Administration

BRIEF-Humanwell Healthcare Group receives subsidy

* Says it received subsidy of 35 million yuan from government, on Nov. 15

BRIEF-Humanwell Healthcare and unit to increase stake in Tianfeng Securities

* Says it and unit plan to acquire additional 2.18 percent stake in Tianfeng Securities for 305.1 million yuan ($45.97 million)

BRIEF-Humanwell Healthcare's 9-month net profit up 211.3 pct y/y

Oct 30 Humanwell Healthcare Group Co Ltd * Says 9-month net profit up 211.3 percent y/y Source text in Chinese: http://bit.ly/2gV5KgU Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Humanwell Healthcare Group unit receives approval for drug clinical trial

* Says unit Yichang Humanwell pharmaceutical Co Ltd received approval for drug clinical trial for a kind of injection M6G, from China Food and Drug Administration

BRIEF-Humanwell Healthcare to invest 805.4 mln yuan in unit RFSW Investment Pte Ltd

* Says it signs agreement to invest 805.4 million yuan ($121.45 million) in unit RFSW Investment Pte. Ltd

BRIEF-Humanwell Healthcare Group unit receives FDA approval

* Says its unit, PuraCap Pharmaceutical LLC, received approval for its Pioglitazone Tablet from U.S Food and Drug Administration

Select another date: